NCT03582293View on ClinicalTrials.gov

Tranexamic Acid to Prevent OpeRation in Chronic Subdural Hematoma

PHASE3RecruitingINTERVENTIONAL
Enrollment

554

Participants

Timeline

Start Date

June 19, 2018

Primary Completion Date

April 30, 2029

Study Completion Date

October 30, 2029

Conditions
Hematoma, Subdural, Chronic
Interventions
DRUG

Tranexamic Acid 500Mg Tablet

orally twice daily for 28 days

DRUG

Placebo oral capsule

Oral placebo capsule two times a day for a total of 28 days

Trial Locations (1)

1100DD

RECRUITING

Academic Medical Center, Amsterdam

All Listed Sponsors
collaborator

ZonMw: The Netherlands Organisation for Health Research and Development

OTHER

lead

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

OTHER